Skip to content

U-100 unit conversion

AOD-9604 calculator

Convert mass and volume to U-100 units. No dose is selected.

These are example numbers so you can see the math. Try yours. Change them to match the vial in your hand.

10U-100 units · 0.1 mL

25 mcg per unit · 2500 mcg/mL

How the calculator works, sources and review dates

AOD-9604 math uses the listed vial sizes on this card and the liquid you type. Concentration in mcg per mL is vial milligrams times 1000, divided by milliliters. A U-100 syringe has 100 marks per milliliter, so each unit is that concentration divided by 100. Example numbers so you can see the math: a 5 mg listing plus 2 mL of liquid. Change any number and the units change. Try the numbers. A research-market vial is not the same material used in a trial.

Editorial review 2026-10-09. source-curated; clinician review pending.

Units chart for listed AOD-9604 sizes

U-100 math for listed AOD-9604 sizes. Each cell is micrograms per syringe mark if you add that much liquid. The table does the same math as the calculator. It does not pick an amount for you.

Micrograms per U-100 unit (100 marks / mL)
Listed vial1 mL liquid2 mL liquid3 mL liquid
5 mg502516.7

What is AOD-9604?

The fragment is not the same as full-length GH or tesamorelin. Seller “5 mg” is a listing size. Papers talk about metabolism. That is not a proven slimming use.

What the evidence says

For each trial, check who or what was studied, which preparation was used and what the findings support before comparing it with personal reports about individual experiences or seller listings that describe a product but don’t establish that it works.

Regulatory context

Regulatory context; not efficacy evidence

No matched treatment-outcome population.

Reported findings. No benefit claim from this context reference.

Nonresponse. Not reported in reviewed excerpt.

Harms. Unknown in reviewed excerpt; absence of mention is not safety evidence.

Limits. Context citations do not fill outcome-evidence gaps.

Preparation: Source preparation; commercial equivalence unverified. Route: Unknown in reviewed excerpt; do not infer.

Read original source ↗

Editorial review 2026-10-09. Clinician review pending.

Human trial

AOD9604 human trial safety synthesis · Journal of Endocrinology and Metabolism 2013

893 adults across six trials; mostly otherwise healthy adults with obesity, 2001–2006.

Reported findings. Authors described tolerability broadly comparable with placebo; generally no significant between-group IGF-1 or glucose-tolerance changes; no detected antibodies in selected samples.

Nonresponse. Weight-loss efficacy was not established by this safety synthesis.

Harms. Headache, gastrointestinal events and euphoria occurred. Severe chest tightness during IV treatment and serious diarrhea in an oral study were considered possibly related; an isolated glucose increase was also reported. These body findings conflict with the abstract’s blanket no-related-serious-event summary.

Limits. Longer studies were oral, up to 24 weeks. Findings do not establish subcutaneous or commercial-product safety. Sponsor-linked summary, selected antibody testing and inconsistent adverse-event wording limit interpretation.

Preparation: Controlled AOD9604 study material; oral capsules/tablets and intravenous preparation, not commercial-vial equivalence. Route: oral and short-term intravenous; no subcutaneous cohort

Read original source ↗

Editorial review 2026-10-09. Clinician review pending.

Regulatory status, dated 2026-10-09

FDA product approval

not established. No US therapeutic product approval is established by this curated source set; other countries and products may differ.

Compounding

not established. Compounded products do not carry FDA product approval; legal eligibility is not established here.

Research

investigational. Animal findings and limited clinical data do not establish a general fat-loss benefit.

Sport

prohibited. WADA S2 lists this growth-hormone fragment.

How long it lasts, how you store it, listed sizes

This entry doesn’t give a duration in hours. No verified formulation-specific human estimate in this source set; no guessed value is supplied.

The units chart uses the 5 mg listing. If your vial is a different mass, type that mass. Do not assume AOD-9604 shares storage with GH secretagogues.

Risks and mix-ups already on the record

  • Safety is incomplete; absence of reports does not establish safety.
  • Unknown or incomplete for research formulations; this is not a clearance for use.
  • Unknown or incomplete; do not infer compatibility with medications or other substances.

People using PepBear often log: Existing clinician-directed records, symptoms and dated health measurements. Record missing data; trends do not demonstrate causation.

Sources

  1. Primary evidence or regulator source · checked 2026-10-09
  2. WADA prohibited list · checked 2026-10-09
  3. AOD-9604 study (PubMed 15670133) · checked 2026-10-09

Questions people ask

Is AOD-9604 a legal compounding bulk substance?

This catalog records compounding as not established. Legal eligibility depends on the facts. This page is not a legal opinion.

Why only one vial size?

The vendor file tied to this id currently lists 5 mg. More sizes will appear on the chart when the catalog file lists them.

How many units is a listed AOD-9604 vial after you add water?

Units = (amount in mcg ÷ (vial mg × 1000 ÷ water mL)) × 100 on a U-100 syringe. Enter the three numbers. The chart shows the same math for each listed vial size and 1, 2 or 3 mL of liquid.

Why flag amounts under 5 units?

A U-100 barrel is easy to misread below about 5 marks. That is a measuring warning. The page does not tell you to take more.

Related cards

A licensed clinician must interpret the evidence for your situation. This entry provides education, not treatment instructions. Not medical advice. PepBear does not pick a dose, a cycle, or a seller.